The Bits in Bio Podcast podcast

Redefining the Undruggable Through Proximity with Armand Cognetta

0:00
36:23
Reculer de 15 secondes
Avancer de 15 secondes

Armand Cognetta, founder and CEO of General Proximity, joins us to explore how proximity medicine is revolutionizing drug discovery by targeting proteins once considered impossible to drug.

We discuss the evolution beyond PROTACs, being a solo bio-founder in Y Combinator, and Armand's journey from imposter syndrome to raising $16M and winning a $3M ARPA-H grant.

From nearly running out of money to building breakthrough platform technology, Armand shares hard-won lessons on fundraising, team building, and maintaining startup speed in an industry known for decade-long timelines.

D'autres épisodes de "The Bits in Bio Podcast"